S-100B is superior to NSE, BDNF and GFAP in predicting outcome of resuscitation from cardiac arrest with hypothermia treatment

Resuscitation

Volumn 82, Issue 1, 2011, Pages 26-31

  Mörtberg, Erik ^a   Zetterberg, Henrik ^b   Nordmark, Johanna ^a   Blennow, Kaj ^b   Rosengren, Lars ^b   Rubertsson, Sten ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Hypothermia; Outcome; Post resuscitation period

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; NEURON SPECIFIC ENOLASE; PROTEIN S100B;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; FEMALE; HEART ARREST; HOSPITAL DISCHARGE; HUMAN; HYPOTHERMIA; INTENSIVE CARE UNIT; MALE; NEUROLOGIC EXAMINATION; OBSERVATIONAL STUDY; PILOT STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RESUSCITATION; RETURN OF SPONTANEOUS CIRCULATION; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; UNCONSCIOUSNESS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CARDIOPULMONARY RESUSCITATION; FEMALE; FOLLOW-UP STUDIES; GLIAL FIBRILLARY ACIDIC PROTEIN; HEART ARREST; HUMANS; HYPOTHERMIA, INDUCED; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PHOSPHOPYRUVATE HYDRATASE; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; S100 PROTEINS; YOUNG ADULT;

EID: 78650782390     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2010.10.011     Document Type: Article

References (29)

1. Nolan J.P., Laver S.R., Welch C.A., Harrison D.A., Gupta V., Rowan K. Outcome following admission to UK intensive care units after cardiac arrest: a secondary analysis of the ICNARC Case Mix Programme Database. Anaesthesia 2007, 62:1207-1216.
2. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002, 346:549-556. Hypothermia_after_Cardiac_Arrest_Study_Group.
3. Bernard S.A., Gray T.W., Buist M.D., et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002, 346:557-563.
4. Edgren E., Hedstrand U., Kelsey S., Sutton-Tyrrell K., Safar P. Assessment of neurological prognosis in comatose survivors of cardiac arrest. BRCT I Study Group. Lancet 1994, 343:1055-1059.
5. Al Thenayan E., Savard M., Sharpe M., Norton L., Young B. Predictors of poor neurologic outcome after induced mild hypothermia following cardiac arrest. Neurology 2008, 71:1535-1537.
6. Bottiger B.W., Mobes S., Glatzer R., et al. Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation 2001, 103:2694-2698.
7. Rosen H., Sunnerhagen K.S., Herlitz J., Blomstrand C., Rosengren L. Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation 2001, 49:183-191.
8. Goncalves C.A., Leite M.C., Nardin P. Biological and methodological features of the measurement of S100B, a putative marker of brain injury. Clin Biochem 2008, 41:755-763.
9. Schmechel D., Marangos P.J., Zis A.P., Brightman M., Goodwin F.K. Brain endolases as specific markers of neuronal and glial cells. Science 1978, 199:313-315.
10. Marangos P.J., Schmechel D. The neurobiology of the brain enolases. Essays Neurochem Neuropharmacol 1980, 4:211-247.
11. Johnsson P., Blomquist S., Luhrs C., et al. Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation. Ann Thorac Surg 2000, 69:750-754.
12. Tiainen M., Roine R.O., Pettila V., Takkunen O. Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia. Stroke 2003, 34:2881-2886.
13. Shinozaki K., Oda S., Sadahiro T., et al. Serum S-100B is superior to neuron-specific enolase as an early prognostic biomarker for neurological outcome following cardiopulmonary resuscitation. Resuscitation 2009, 80:870-875.
14. Rundgren M., Karlsson T., Nielsen N., Cronberg T., Johnsson P., Friberg H. Neuron specific enolase and S-100B as predictors of outcome after cardiac arrest and induced hypothermia. Resuscitation 2009, 80:784-789.
15. Barde Y.A., Edgar D., Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982, 1:549-553.
16. Binder D.K., Scharfman H.E. Brain-derived neurotrophic factor. Growth Factors 2004, 22:123-131.
17. D'Cruz B.J., Fertig K.C., Filiano A.J., Hicks S.D., DeFranco D.B., Callaway C.W. Hypothermic reperfusion after cardiac arrest augments brain-derived neurotrophic factor activation. J Cereb Blood Flow Metab 2002, 22:843-851.
18. Eng L.F., Ghirnikar R.S., Lee Y.L. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 2000, 25:1439-1451.
19. Herrmann M., Vos P., Wunderlich M.T., de Bruijn C.H., Lamers K.J. Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke 2000, 31:2670-2677.
20. Nylen K., Ost M., Csajbok L.Z., et al. Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome. J Neurol Sci 2006, 240:85-91.
21. Nylen K., Csajbok L.Z., Ost M., et al. Serum glial fibrillary acidic protein is related to focal brain injury and outcome after aneurysmal subarachnoid hemorrhage. Stroke 2007, 38:1489-1494.
22. Kaneko T., Kasaoka S., Miyauchi T., et al. Serum glial fibrillary acidic protein as a predictive biomarker of neurological outcome after cardiac arrest. Resuscitation 2009, 80:790-794.
23. Jennett B., Bond M. Assessment of outcome after severe brain damage. Lancet 1975, 1:480-484.
24. Cummins R.O., Chamberlain D., Hazinski M.F., et al. Recommended guidelines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital 'Utstein style'. A statement for healthcare professionals from the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, the Australian Resuscitation Council, and the Resuscitation Councils of Southern Africa. Resuscitation 1997, 34:151-183.
25. Zetterberg H., Tanriverdi F., Unluhizarci K., Selcuklu A., Kelestimur F., Blennow K. Sustained release of neuron-specific enolase to serum in amateur boxers. Brain Inj 2009, 23:723-726.
26. Haimoto H., Hosoda S., Kato K. Differential distribution of immunoreactive S100-alpha and S100-beta proteins in normal nonnervous human tissues. Lab Invest 1987, 57:489-498.
27. Oksanen T., Tiainen M., Skrifvars M.B., et al. Predictive power of serum NSE and OHCA score regarding 6-month neurologic outcome after out-of-hospital ventricular fibrillation and therapeutic hypothermia. Resuscitation 2009, 80:165-170.
28. Wolff B., Machill K., Schumacher D., Schulzki I., Werner D. Early achievement of mild therapeutic hypothermia and the neurologic outcome after cardiac arrest. Int J Cardiol 2009, 133:223-228.
29. Nielsen N., Hovdenes J., Nilsson F., et al. Outcome, timing and adverse events in therapeutic hypothermia after out-of-hospital cardiac arrest. Acta Anaesthesiol Scand 2009, 53:926-934.